G
EW icon

GenTrust’s Edwards Lifesciences EW Stock Holding History

GenTrust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,345
Closed -$223K – 128
2022
Q2 		$223K Hold
2,345
– – 0.02% 131
2022
Q1 		$276K Hold
2,345
– – 0.02% 124
2021
Q4 		$254K Sell
2,345
-508
-18% -$59.3K 0.02% 130
2021
Q3 		$323K Buy
2,853
+508
+22% +$58K 0.03% 112
2021
Q2 		$243K Buy
+2,345
New +$221K 0.02% 128
2021
Q1 		– Sell
-2,345
Closed -$214K – 149
2020
Q4 		$214K Sell
2,345
-300
-11% -$24.9K 0.02% 106
2020
Q3 		$211K Buy
+2,645
New +$206K 0.02% 100

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

GenTrust's EW Position: Q3 2022 in Review

GenTrust sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 2,345 shares — an estimated $223K sold.

GenTrust first reported a position in EW in Q3 2020 and held it in 7 quarters. The position peaked at $323K in Q3 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • GenTrust reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • GenTrust sold 2,345 Edwards Lifesciences shares in Q3 2022, an estimated $223K.
  • GenTrust first reported a position in Edwards Lifesciences in Q3 2020 and held it in 7 quarters.
  • GenTrust's Edwards Lifesciences position peaked at $323K in Q3 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on GenTrust's 13F filing for Q3 2022, filed 21 Oct 2022.